UNSPSC 51433608: Perhexiline maleate

This classification denotes a calcium channel blocker with the molecular formula C19H35N.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K7V8Y90G0H, chemically known as 2-(2,2-dicyclohexylethyl)piperidinium hydrogen maleate but more generally known as perhexiline maleate, which bears US NIH Compound Identifier 5284439. European Medicines Agency schedules Perhexiline maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03710MIG.

Most nations, for tariff and trade purposes, schedule perhexiline maleate under HS 29333999 and SITC 51574. As of Q4 2014, PERHEXILINE MALEATE remains US FDA's Preferred Term for this commodity. Perhexiline maleate bears US NLM identifiers UMLS ID C0070413 and NCI Concept Code C90822. SMILES: C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51433608 Perhexiline maleate is a Commodity code that describes a specific pharmaceutical active ingredient used in cardiac care. State and local governments procure this substance as part of broader advanced life support medication supply contracts for emergency medical services, fire departments, and hospital systems. The recent solicitation activity shows that jurisdictions are buying perhexiline maleate and related cardiac medications in standardized doses (vials, injections, tablets) bundled with other emergency pharmaceuticals rather than as standalone line items. Issuing bodies under this code include municipal fire departments and city purchasing offices acting on their behalf. Vendors must comply with strict expiration-date requirements (typically nine months or more from acceptance), warranty periods of at least 365 days, and take responsibility for pickup and replacement of expired stock. All materials must be accompanied by Safety Data Sheets compliant with OSHA Hazard Communication Standards, and vendors must meet accessibility standards including WCAG 2.2 Level AA conformance.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) on April 24, 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026 and an estimated contract value of $40,000. The bid was sheltered for Small Local Business Enterprises with a 5 percent discount not to exceed $10,000. The contract term runs for one year from award with two optional one-year renewals and an additional three 30-day unilateral extension periods at the city's discretion. Recent activity is concentrated in Florida; the source provides no evidence of perhexiline maleate procurement in other states or from other issuing bodies.